Trump's controversial administration nominees signal global ramifications for drug regulation, health funding and pharmaceutical investment.

Confirmation of Trump's nominations for appointments is not yet assured and the Senate will vote to approve them early in ...

Health and Human Services (HHS) has unveiled a proposal to expand Medicare and Medicaid coverage to include weight loss drugs ...

Prospective HHS secretary RFK Jr has drawn praise and criticism from the left and the right. So is his nomination cause for ...

President-elect Donald Trump’s announcement of Robert F. Kennedy Jr. as his choice to be secretary of Health and Human ...

Almost all have been highly critical of the agencies they would run if confirmed, and experts say the nominees represent a ...

Robert F. Kennedy Jr. is known first and foremost for his anti-vaccine crusades. However, he has also been saying some things ...

President-elect Trump has nominated biotech investor Jim O’Neill for deputy secretary of the Health and Human Services ...

Bhattacharya is a physician and professor at Stanford University School of Medicine, and is a critic of pandemic lockdowns ...

They say that Kennedy described the COVID-19 vaccine as a "crime against humanity" and downplayed the infectious disease as a ...

The proposal would let patients get Wegovy, Ozempic and related drugs for obesity, which Medicare and Medicaid does not cover ...

Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Zepbound c ...